Andrea Newkirk
Stock Analyst at Goldman Sachs
(3.04)
# 1,295
Out of 5,182 analysts
4
Total ratings
100%
Success rate
156.2%
Average return
Main Sectors:
Stocks Rated by Andrea Newkirk
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SDGR Schrödinger | Initiates: Neutral | $19 | $12.24 | +55.23% | 1 | Sep 30, 2025 | |
| RVMD Revolution Medicines | Maintains: Buy | $65 → $73 | $144.83 | -49.60% | 2 | Sep 12, 2025 | |
| ALKS Alkermes | Initiates: Buy | $43 | $34.14 | +25.95% | 1 | Jul 15, 2025 |
Schrödinger
Sep 30, 2025
Initiates: Neutral
Price Target: $19
Current: $12.24
Upside: +55.23%
Revolution Medicines
Sep 12, 2025
Maintains: Buy
Price Target: $65 → $73
Current: $144.83
Upside: -49.60%
Alkermes
Jul 15, 2025
Initiates: Buy
Price Target: $43
Current: $34.14
Upside: +25.95%